BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The National Drug Abuse Treatment Clinical Trials Network - Northeast Node - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The National Drug Abuse Treatment Clinical Trials Network - Northeast Node
X-ORIGINAL-URL:https://www.ctnnortheastnode.org
X-WR-CALDESC:Events for The National Drug Abuse Treatment Clinical Trials Network - Northeast Node
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20150308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20151101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20160313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20161106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20170312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20171105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241205T120000
DTEND;TZID=America/New_York:20241205T133000
DTSTAMP:20260502T115343
CREATED:20241203T190911Z
LAST-MODIFIED:20241203T191015Z
UID:3358-1733400000-1733405400@www.ctnnortheastnode.org
SUMMARY:Science Series: Medications for Opioid Use Disorder for Youth
DESCRIPTION:Topic Summary \nIn 2021\, one in every 100 kids aged 12-17 had an Opioid Use Disorder (OUD). Medication treatment for OUD (MOUD) is effective\, but only 3-4% of youth who need it receive treatment. This session will outline features of youth treatment for OUD\, evidence for treating youth with medications\, youth MOUD uptake and retention\, the role of families in care\, and opportunities for interdisciplinary care teams in outpatient settings. In this extended session\, Dr. Fishman will also facilitate interactive case reviews with attendees. If you have a case that you would like to present\, please let us know. \nSpeaker Bio \nDr. Fishman is an addiction psychiatrist with extensive experience in clinical care of addiction patients\, addiction research\, and program development and administration in the real world. He leads Maryland Treatment Centers / Mountain Manor\, a regional behavioral healthcare provider\, which offers programs for residential and outpatient SUD and co-occurring treatment for youth and adults. He is a member of the psychiatry faculty at Johns Hopkins University School of Medicine. He has been an investigator on numerous research studies in addiction and published extensively in the field. His academic and research work has focused on addiction pharmacotherapy\, particularly in OUD; models of care for youth; and treatment placement and matching strategies. He was a member of the Guideline Committee that developed the American Society of Addiction Medicine (ASAM) National Practice Guideline for the Treatment of OUD in 2015 and its update in 2020. He served as a co-editor for past editions of the ASAM Criteria for the Treatment of Substance-Related Disorders. He served as a past President of the Maryland Society of Addiction Medicine.
URL:https://www.ctnnortheastnode.org/event/science-series-medications-for-opioid-use-disorder-for-youth/
LOCATION:Webinar
CATEGORIES:Northeast Node
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230929T080000
DTEND;TZID=America/New_York:20230929T163000
DTSTAMP:20260502T115343
CREATED:20230822T162645Z
LAST-MODIFIED:20230822T162901Z
UID:3264-1695974400-1696005000@www.ctnnortheastnode.org
SUMMARY:Addressing the Intersection of Pain Management and Opioid Use: Integrating Care to Promote Healthy Outcomes
DESCRIPTION:This hybrid full-day training summit will explore the clinical intersection of pain and opioid use. Interdisciplinary attendees will learn about evidence-based practices (pharmacological and non) for treating these complex and often co-occurring conditions. More information \nIn-person participation is preferred\, though a virtual option is also available. This Summit will focus on addressing pain and opioid use from a team-based approach; as such\, virtual attendees may not get the same experience as those who attend in-person.\n\nRegister Now
URL:https://www.ctnnortheastnode.org/event/addressing-the-intersection-of-pain-management-and-opioid-use-integrating-care-to-promote-healthy-outcomes/
CATEGORIES:Northeast Node
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210311T120000
DTEND;TZID=America/New_York:20210311T130000
DTSTAMP:20260502T115343
CREATED:20210310T180418Z
LAST-MODIFIED:20210310T180418Z
UID:2508-1615464000-1615467600@www.ctnnortheastnode.org
SUMMARY:Science Series: Injectable Extended-Release Buprenorphine Treatment in the Fentanyl Era
DESCRIPTION:Presenter \nJohn J. Mariani\, MD\nDirector\, Substance Treatment and Research and Services (STARS)\nAssociate Professor of Clinical Psychiatry at Columbia University Irving Medical Center/New York State Psychiatry Institute \nTopic \nReview of:\n•Frequency of injection drug use among patients receiving MOUD and potential health consequences\n•Prevalence/incidence of buprenorphine use by non-prescribed routes of administration\n•Potential consequences of buprenorphine injection misuse\n•Therapeutic strategies for identifying and responding to injecting behaviors in MOUD patients \n  \nZoom Link: https://dartmouth.zoom.us/j/423790798?pwd=MEQ0VklVRFJrZmJGL1A5MDhROTRkQT09
URL:https://www.ctnnortheastnode.org/event/science-series-injectable-extended-release-buprenorphine-treatment-in-the-fentanyl-era/
CATEGORIES:Northeast Node
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210204T120000
DTEND;TZID=America/New_York:20210204T130000
DTSTAMP:20260502T115344
CREATED:20210111T041229Z
LAST-MODIFIED:20210111T041229Z
UID:2336-1612440000-1612443600@www.ctnnortheastnode.org
SUMMARY:Science Series
DESCRIPTION:Topic: Working at the Intersections of Intimate Partner Violence\, Opioids\, and Trauma \nPresenters: \nCarole Warshaw\, MD\nGabriela Zapata-Alma\, LCSW\, CADC\nNational Center on Domestic Violence\, Trauma and Mental Health \nZoom Link:\nhttps://dartmouth.zoom.us/j/423790798?pwd=MEQ0VklVRFJrZmJGL1A5MDhROTRkQT09 \nMeeting ID: 423 790 798\nPasscode: 6467086 \nOne tap mobile\n+16465588656\,\,423790798#\,\,\,\,\,\,0#\,\,6467086# US (New York)\n+13017158592\,\,423790798#\,\,\,\,\,\,0#\,\,6467086# US (Washington D.C)
URL:https://www.ctnnortheastnode.org/event/science-series-2/
CATEGORIES:Northeast Node
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201112T120000
DTEND;TZID=America/New_York:20201112T130000
DTSTAMP:20260502T115344
CREATED:20200921T150552Z
LAST-MODIFIED:20200921T150552Z
UID:2096-1605182400-1605186000@www.ctnnortheastnode.org
SUMMARY:Science Series: RAM: Vermont’s Rapid Access to Medication Assisted Treatment Project
DESCRIPTION:More information to come. \nZoom Link: https://dartmouth.zoom.us/j/423790798
URL:https://www.ctnnortheastnode.org/event/science-series-ram-vermonts-rapid-access-to-medication-assisted-treatment-project/
CATEGORIES:Northeast Node
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201001T120000
DTEND;TZID=America/New_York:20201001T130000
DTSTAMP:20260502T115344
CREATED:20200921T150355Z
LAST-MODIFIED:20200921T150355Z
UID:2094-1601553600-1601557200@www.ctnnortheastnode.org
SUMMARY:Science Series: Evaluating Preferences for Medication for Opioid Use Disorder Formulation and Treatment Model Among People with Opioid Use Disorders (OUD): A Mixed-Methods Study
DESCRIPTION:Topic: Treatment for opioid use disorders (OUD) has changed significantly\, including the development of long-acting medication for opioid use disorder (MOUD) formulations\, and integrated treatment models systematically addressing both behavioral and physical health. More information on patient preference for these innovations is necessary to inform a patient-centered treatment system for OUD. This presentation will review a series of mixed-methods studies using exploring preferences for medication formulation and treatment model among people with OUD. \nPresenter: Dr. Elizabeth Saunders \nZoom Link: https://dartmouth.zoom.us/j/423790798
URL:https://www.ctnnortheastnode.org/event/science-series-evaluating-preferences-for-medication-for-opioid-use-disorder-formulation-and-treatment-model-among-people-with-opioid-use-disorders-oud-a-mixed-methods-study/
CATEGORIES:Northeast Node
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200625T120000
DTEND;TZID=America/New_York:20200625T130000
DTSTAMP:20260502T115344
CREATED:20200515T144305Z
LAST-MODIFIED:20200515T144305Z
UID:1740-1593086400-1593090000@www.ctnnortheastnode.org
SUMMARY:Science Series: Responding to the Opioid Epidemic's "Ripple Effect" through Integrated Family Care: The Policy and Payment Landscape
DESCRIPTION:Topic  \nIn November of 2019\, the United Hospital Fund (UHF)\, an independent nonprofit health care policy organization based in New York\, released first-of-its-kind national and state estimates of the toll of the U.S. opioid epidemic on children. In this talk\, Suzanne Brundage\, director of Children’s Health at UHF and principle investigator will: \n\ndescribe the estimate impact of the opioid epidemic on New Hampshire’s children today and by 2030;\ndiscuss emerging integrated models of health care that address family addiction and other family-based behavioral health challenges;\nOutline key policy and payment challenges and opportunities for sustaining these new models of care.\n\nAbout the Presenter \nSuzanne C. Brundage is the director of the United Hospital Fund’s Children’s Health Initiative\, which was established to strengthen health care’s focus on health disparities rooted in childhood. Through a dual focus on service delivery and policy\, Suzanne has worked on a range of issues including social determinants of health and education; primary care; Medicaid; and substance use disorders. She is a trusted collaborators through partner\, and consensus building for many organizations and individuals nationwide focused on strengthening systems for families. She was named the first Patricia S. Levinson Fellow at UHF for her work to improve health care for vulnerable populations. She holds a BA from Bennington College in conflict resolution and international affairs and an MS in health policy and management from the Harvard T.H. Chan School of Public Health.
URL:https://www.ctnnortheastnode.org/event/science-series-responding-to-the-opioid-epidemics-ripple-effect-through-integrated-family-care-the-policy-and-payment-landscape/
CATEGORIES:Northeast Node
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190523T120000
DTEND;TZID=America/New_York:20190523T130000
DTSTAMP:20260502T115344
CREATED:20190513T155639Z
LAST-MODIFIED:20190513T155802Z
UID:1361-1558612800-1558616400@www.ctnnortheastnode.org
SUMMARY:SCIENCE SERIES: Opioid Pharmacotherapies for Primary Care and Criminal Justice Populations
DESCRIPTION:Title: Opioid Pharmacotherapies for Primary Care and Criminal Justice Populations: Low Threshold\, Low Barrier Approaches to Naltrexone and Buprenorphine Treatments \nWhen: Thursday\, May 23\, 2019\, 12:00-1:00 PM Eastern Standard Time \nWhere: 46 Centerra Parkway\, Aquarium Conference Room\, Suite 315\, Lebanon\, NH 03766 or via WebEx  \nTopic description: Clinical trials and practice-based research indicates a relatively simple\, medical management approaches to opioid use disorder treatments are feasible\, effective\, and easily disseminated.  These ‘low threshold’ models value wide inclusion criteria\, minimal additional mandates for counseling or psychosocial supports\, immediate and sustained access to medications\, and regular but not intensive follow-up to support medication adherence and good clinical outcomes.  We have conducted multiple clinical trials using these low threshold\, low barrier packaging of buprenorphine and naltrexone therapies for opioid use disorder in primary care settings\, among detox-to-outpatient cohorts\, and in jail-to-community and parole/probation populations. \nAbout the presenter: Joshua D. Lee\, MD\, MSc\, is an Associate Professor of Population Health and Medicine/General Internal Medicine and Clinical Innovation at the NYU School of Medicine and Director of the NYU Fellowship in Addiction Medicine. He is a clinician researcher focused on addiction pharmacotherapies in primary care as and criminal justice populations. He has conducted multiple NIH clinical trials examining the use of naltrexone and buprenorphine opioid and alcohol treatments in community criminal justice involved adults\, at release from jail\, and within community primary care settings. \nCredit: Attendees can claim 1.0 CME/CEU for this session \nEmail Northeast.Node.CTN@dartmouth.edu for more details
URL:https://www.ctnnortheastnode.org/event/science-series-opioid-pharmacotherapies-primary-care-criminal-justice-populations/
LOCATION:Northeast Node Headquarters\, 46 Centerra Parkway\, Suite 315\, Lebanon\, NH\, 03766\, United States
CATEGORIES:Northeast Node
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190314T120000
DTEND;TZID=America/New_York:20190314T130000
DTSTAMP:20260502T115344
CREATED:20190131T134900Z
LAST-MODIFIED:20190131T134900Z
UID:1202-1552564800-1552568400@www.ctnnortheastnode.org
SUMMARY:SCIENCE SERIES: Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder
DESCRIPTION:This presentation will provide an update on a CTN trial examining a pharmacotherapy treatment for methamphetamine use disorder\, led by Dr. Madhukar Trivedi of the University of Texas Southwestern Medical Center. \nFurther details coming soon! \n  \nJoin us in-person at 46 Centerra Parkway\, Suite 315 (Aquarium Conference Room)\, Lebanon\, NH or join via WebEx. For more details email Northeast.Node.CTN@dartmouth.edu \nAttendees can claim 1.0 CME/CEU credit for this session.
URL:https://www.ctnnortheastnode.org/event/science-series-accelerated-development-additive-pharmacotherapy-treatment-adapt-2-methamphetamine-use-disorder/
LOCATION:Northeast Node Headquarters\, 46 Centerra Parkway\, Suite 315\, Lebanon\, NH\, 03766\, United States
CATEGORIES:Northeast Node
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190124T120000
DTEND;TZID=America/New_York:20190124T130000
DTSTAMP:20260502T115344
CREATED:20181116T174359Z
LAST-MODIFIED:20181116T174359Z
UID:1124-1548331200-1548334800@www.ctnnortheastnode.org
SUMMARY:SCIENCE SERIES: Using the ECHO model to treat the opioid crisis in rural Northeast America
DESCRIPTION:Please join our mailing list to receive notifications about this Science Series event! \nTopic \nClinicians can often find it both challenging and daunting to identify their role in addressing the epidemics of opioid misuse and drug overdose deaths facing the nation\, particularly in the hard-hit area of northern New England.  In an effort to engage and support clinicians in these efforts\, Maine Quality Counts (QC) and its partners in the Northern New England ECHO (NNE ECHO) initiative have used the proven “Project ECHO” model to provide direct education and support using the ECHO model of web-supported\, case-based learning.  The NNE ECHO initiative has hosted several opioid-related programs to date\, including compassionate tapering of opioids; SUD care through the perinatal period; Medications for Addiction Treatment (MAT); and bringing key community sectors together to decrease drug overdose deaths within local communities.  In this session\, Jeanne Ryer (NH Citizens Health Initiative at UNH) and Lisa Letourneau (Maine Quality Counts) will provide an introduction to the ECHO model\, and describe how their organizations have used ECHO programs to engage and support clinicians and communities in addressing the opioid epidemic. \n  \nAbout the Presenters \nDr. Lisa Letourneau is a physician leader and passionate advocate for health care system delivery change\, with a particular interest in advancing primary care and patient engagement efforts. She previously served for as Executive Director of Maine Quality Counts\, a regional health improvement collaborative\, where she led several quality improvement efforts including the Maine Aligning Forces for Quality initiative and the Maine Patient Centered Medical Home (PCMH) Pilot. Dr. Letourneau is a graduate of Brown University and the Dartmouth-Brown Program in Medicine and is a board-certified internist who practiced emergency medicine for seven years before beginning her work in clinical quality improvement. She holds a master’s degree from the Harvard School of Public Health and has a particular interest in helping to build connections between public health and clinical care\, and the role of physicians in helping to develop and lead health improvement efforts. \nJeanne Ryer is the Director of the NH Citizens Health Initiative (NHCHI)\, a multi-stakeholder statewide effort to create a system of care that promotes health\, assures quality and makes care affordable\, effective\, and accessible to all New Hampshire residents. NHCHI is a project under the NH Institute for Health Policy and Practice. \nFrom 2003 until 2011\, Jeanne was Program Director at the Endowment for Health\, New Hampshire’s statewide health foundation\, where she managed a portfolio of grants\, projects\, and policy initiatives addressing economic and geographic barriers to health. Her work focused on state and federal health system reforms\, safety net health services\, and community transportation. She led efforts to develop and implement a Mission Related Investment strategy to create the Safety Net Loan Fund\, a working capital loan fund for safety net primary care\, mental health\, and oral health clinics. Before joining the Endowment\, Jeanne served as Senior Program Officer for the New Hampshire Charitable Foundation and served as lead staff for the Lakes Region Charitable Foundation. Prior to that\, she was the principal of a consulting firm specializing in community health and human services planning and primary health care access\, focusing on the needs of the underserved in rural and remote areas. \nJeanne’s research and professional interests include population perceptions of health and well-being and the use of multi-stakeholder collaboratives in health systems transformation. She is author and co-author of several books\, including one of the early guides to the Internet and others on accessing health and medical information online. \nJeanne serves on the Legislative Commission on Primary Care Workforce\, the New England Comparative Effectiveness Public Advisory Council\, the Board of Trustees of the Foundation for Healthy Communities\, and the Steering Committee for ReThink Health of the Upper Connecticut River Valley.
URL:https://www.ctnnortheastnode.org/event/science-series-using-echo-model-treat-opioid-crisis-rural-northeast-america/
LOCATION:Northeast Node Headquarters\, 46 Centerra Parkway\, Suite 315\, Lebanon\, NH\, 03766\, United States
CATEGORIES:Northeast Node
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190116T140000
DTEND;TZID=America/New_York:20190116T150000
DTSTAMP:20260502T115344
CREATED:20190109T145800Z
LAST-MODIFIED:20190109T150023Z
UID:1174-1547647200-1547650800@www.ctnnortheastnode.org
SUMMARY:CTN Webinar: Utilizing a Robust and Comprehensive Locator Form as a Retention Tool in Clinical Trials
DESCRIPTION:Phoebe Gauthier\, MA\, MPH from the Northeast Node and Dagmar Salazar\, MS from NDAT CTN Clinical Coordinating Center will present on “Utilizing a Robust and Comprehensive Locator Form as a Retention Tool in Clinical Trials” on January 16th. \nParticipant recruitment and retention are critical aspects of conducting quality clinical research projects. The National Drug Abuse Treatment Clinical Trials Network (NDAT CTN)\, which evaluates behavioral\, pharmacological\, and integrated treatment interventions for substance use disorders\, routinely enrolls participants who may be challenging to locate during the treatment and follow-up phase of a trial. This 20-minute presentation will review one tool for increasing retention—an adapted locator form. This locator form is designed to better facilitate locating participants\, especially those with unstable living conditions or with limited contact information. Additionally\, this presentation will discuss the form elements beyond conventional locator forms and methods for collecting the information to help increase participant retention. \nLEARNING OBJECTIVES: \n· Outline the elements of a comprehensive and robust locator form.\n· Analyze procedural implications for effective implementation of the locator form.\n· Review best practices when collecting contact information with the locator form. \nThey will also be joined by presenters from the Ohio Valley Node whose theme will also focus on study participant retention strategies and tools. \nRegister here: https://cc.readytalk.com/registration/#/?meeting=oc60vlwip9eu&campaign=gi7gdsjt78ri
URL:https://www.ctnnortheastnode.org/event/ctn-webinar-utilizing-robust-comprehensive-locator-form-retention-tool-clinical-trials/
LOCATION:Web Based
CATEGORIES:Clinical Trials Network,Northeast Node
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20181115T120000
DTEND;TZID=America/New_York:20181115T130000
DTSTAMP:20260502T115344
CREATED:20170619T162116Z
LAST-MODIFIED:20181001T135105Z
UID:525-1542283200-1542286800@www.ctnnortheastnode.org
SUMMARY:Science Series: Mary Kay Jankowski\, PhD and Erin Knight\, PhD
DESCRIPTION:Parental Substance Misuse and Child Trauma\n \nThe Science Series webinars are presented on a bi-monthly academic calendar during the lunch hour. Presentations can be viewed either in person or via WebEx (see our Science Series page for online viewing link). We do provide lunch for the in-person participants.
URL:https://www.ctnnortheastnode.org/event/science-series-mary-kay-jankowski-phd/
LOCATION:Northeast Node Headquarters\, 46 Centerra Parkway\, Suite 315\, Lebanon\, NH\, 03766\, United States
CATEGORIES:Northeast Node
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180927T120000
DTEND;TZID=America/New_York:20180927T130000
DTSTAMP:20260502T115344
CREATED:20180226T155345Z
LAST-MODIFIED:20180418T195734Z
UID:818-1538049600-1538053200@www.ctnnortheastnode.org
SUMMARY:Science Series: What’s the Point? Harm Reduction through Syringe Exchange in White River Junction and Springfield\, VT\, by Laura Byrne
DESCRIPTION:Syringe exchange programs are more than just a place to trade in used needles for new ones. These programs offer a variety of services such as HIV and Hepatitis C testing\, naloxone and referrals to substance misuse treatment and other services. This talk will examine and compare two syringe exchange programs run by the HIV/HCV Resource Center\, one at the Good Neighbor Heath Clinic and the other at Springfield Health Center. The talk will focus on client demographics\, risk behaviors\, drug use\, Hepatitis C transmission and prevalence and the role of stigma as an impediment to accessing services. \nLaura Byrne is Executive Director of the HIV/HCV Resource Center\, an AIDS Service Organization located in Lebanon\, NH. She has administered the agency’s White River Junction syringe exchange program since 2010 and the Springfield program since 2017. With degrees from Colby College (BA) and Boston University (MA)\, she is an anthropologist by training and has also lived and studied abroad. In addition to promoting increased access to services and harm reduction for injection drug users\, she is interested in relationships between gender\, identity\, society and culture. \nCheck out our Science Series page for more information and to view past presentations.
URL:https://www.ctnnortheastnode.org/event/science-series-whats-point-harm-reduction-syringe-exchange-white-river-junction-springfield-vt-laura-byrne/
LOCATION:Northeast Node Headquarters\, 46 Centerra Parkway\, Suite 315\, Lebanon\, NH\, 03766\, United States
CATEGORIES:Northeast Node
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180524T120000
DTEND;TZID=America/New_York:20180524T130000
DTSTAMP:20260502T115344
CREATED:20180120T030332Z
LAST-MODIFIED:20180120T030407Z
UID:644-1527163200-1527166800@www.ctnnortheastnode.org
SUMMARY:Science Series: Opioid Use Disorder and Commonly Co-Occurring Conditions: an Infectious Disease Perspective
DESCRIPTION:Dr. Kinna Thakarar\nPeople with opioid use disorder who inject drugs commonly have co-occurring infectious disease conditions like HIV\, viral hepatitis\, and infective endocarditis. This presentation will review the epidemiology behind injection drug use (IDU) and infectious diseases\, a clinical checklist for key health issues among people who inject drugs (PWID) with a focus on harm reduction and infection prevention\, and findings from a recent study of Maine Medical Center patients with IDU-associated infective endocarditis. \nPlease see our Science Series page for more information.
URL:https://www.ctnnortheastnode.org/event/science-series/
LOCATION:Northeast Node Headquarters\, 46 Centerra Parkway\, Suite 315\, Lebanon\, NH\, 03766\, United States
CATEGORIES:Northeast Node
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180329T120000
DTEND;TZID=America/New_York:20180329T130000
DTSTAMP:20260502T115344
CREATED:20180328T132805Z
LAST-MODIFIED:20180328T132805Z
UID:860-1522324800-1522328400@www.ctnnortheastnode.org
SUMMARY:Science Series: Pharmacotherapy for Treating People with Alcohol Use Disorder\, by Dr. Mary F. Brunette
DESCRIPTION:Alcohol use disorder is a common chronic condition. Although multiple pharmacotherapies have been shown to reduce drinking in people with this disorder\, these important treatment strategies are underutilized. Dr. Mary Brunette will provide an overview of how to conduct assessments and provide evidence-based pharmacologic management for people with alcohol use disorders in primary and specialty care settings. \nDr. Mary F. Brunette is an Associate Professor of Psychiatry at Geisel School of Medicine at Dartmouth and the Medical Director of the Bureau of Mental Health Services within the New Hampshire Department of Health and Human Services. As a board-certified addiction psychiatrist\, she has been involved with research and clinical care of patients with mental illnesses and co-occurring substance use disorders for over 20 years. She has been active with both psychosocial research and clinical trials studying treatments for people with these co-occurring disorders and other disadvantaged populations. In the past few years\, she initiated a program of research on smoking cessation for people with mental illnesses\, and has been involved in studying the use of technology to increase the efficacy and expand the research of treatments for people with co-occurring disorders\, with a focus on people with severe mental illnesses in general and nicotine addiction in particular. \nThis installment of the Northeast Node’s Science Series will be available via BlueJeans.com at https://bluejeans.com/191888382 (We recommend that you visit BlueJeans.com prior to the presentation so that you can download the BlueJeans client/app). \nThis presentation will also be recorded and archived on our website\, www.ctnnortheastnode.org\, alongside previous Science Series presentations. \nWe are anticipating a large number of attendees at this session\, so please be sure to let us know if you plan to attend in person.
URL:https://www.ctnnortheastnode.org/event/science-series-pharmacotherapy-treating-people-alcohol-use-disorder-dr-mary-f-brunette/
LOCATION:Northeast Node Headquarters\, 46 Centerra Parkway\, Suite 315\, Lebanon\, NH\, 03766\, United States
CATEGORIES:Northeast Node
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180104T120000
DTEND;TZID=America/New_York:20180104T130000
DTSTAMP:20260502T115344
CREATED:20170619T161929Z
LAST-MODIFIED:20180120T023710Z
UID:524-1515067200-1515070800@www.ctnnortheastnode.org
SUMMARY:Science Series: Initiating Treatment of Opioid Use Disorder in the Emergency Department
DESCRIPTION:Dr. Ryan McCormack and Dr. Kathryn Hawk\nThe Emergency Department (ED) is a critical venue to initiate SUD interventions. ED patients have a disproportionately high prevalence of SUD\, are at an elevated risk of overdose\, and many do not access healthcare elsewhere. Despite this\, SUD interventions are rarely initiated in EDs. Drs. Hawk and McCormack will review common barriers to initiating treatment in the ED\, including stigma\, lack of resources\, and perceptions of SUD as chronic\, non-emergent conditions more appropriately addressed elsewhere. Drawing on recent and ongoing research\, they will describe best practices for the treatment of opioid use disorder and alcohol use disorder in the ED. Interventions to be discussed include ED-initiated buprenorphine\, extended-release naltrexone\, and naloxone distribution. \n  \nSee the Science Series for more information.
URL:https://www.ctnnortheastnode.org/event/science-series-tbd/
LOCATION:Northeast Node Headquarters\, 46 Centerra Parkway\, Suite 315\, Lebanon\, NH\, 03766\, United States
CATEGORIES:Northeast Node
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20171116T120000
DTEND;TZID=America/New_York:20171116T130000
DTSTAMP:20260502T115344
CREATED:20170619T152738Z
LAST-MODIFIED:20170619T152738Z
UID:519-1510833600-1510837200@www.ctnnortheastnode.org
SUMMARY:Science Series: Mary Brunette\, MD
DESCRIPTION:Smoking cessation in addiction treatment\nThe Science Series webinars are presented on a bi-monthly academic calendar during the lunch hour. Presentations can be viewed either in person or via WebEx (see our Science Series page for online viewing link). We do provide lunch for the in-person participants.
URL:https://www.ctnnortheastnode.org/event/science-series-mary-brunette-md/
LOCATION:Northeast Node Headquarters\, 46 Centerra Parkway\, Suite 315\, Lebanon\, NH\, 03766\, United States
CATEGORIES:Northeast Node
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20170921T120000
DTEND;TZID=America/New_York:20170921T130000
DTSTAMP:20260502T115344
CREATED:20170619T152538Z
LAST-MODIFIED:20170619T152538Z
UID:518-1505995200-1505998800@www.ctnnortheastnode.org
SUMMARY:Science Series: Emre Ertin\, PhD
DESCRIPTION:Developing smartwatches to detect substance use\nThe Science Series webinars are presented on a bi-monthly academic calendar during the lunch hour. Presentations can be viewed either in person or via WebEx (see our Science Series page for online viewing link). We do provide lunch for the in-person participants. \n 
URL:https://www.ctnnortheastnode.org/event/science-series-emre-ertin-phd/
LOCATION:Northeast Node Headquarters\, 46 Centerra Parkway\, Suite 315\, Lebanon\, NH\, 03766\, United States
CATEGORIES:Northeast Node
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20170912T120000
DTEND;TZID=America/New_York:20170912T133000
DTSTAMP:20260502T115344
CREATED:20170906T182023Z
LAST-MODIFIED:20170906T182023Z
UID:583-1505217600-1505223000@www.ctnnortheastnode.org
SUMMARY:Understanding the Increase in Opioid Overdoses: NDEWS New Hampshire HotSpot Study Results
DESCRIPTION:Lisa A. Marsch\, Ph.D.\nDirector\, Dartmouth Center for Technology and Behavioral Health\nDirector\, Northeast Node of the National Drug Abuse Clinical Trials Network\nAndrew G. Wallace Professor\, Geisel School of Medicine at Dartmouth College \nMarcella H. Sorg\, Ph.D.\nResearch Professor\, Department of Anthropology\nDirector\, Rural Drug and Alcohol Research Program\nMargaret Chase Smith Policy Center\, University of Maine
URL:https://www.ctnnortheastnode.org/event/understanding-increase-opioid-overdoses-ndews-new-hampshire-hotspot-study-results/
CATEGORIES:Northeast Node
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20170518T120000
DTEND;TZID=America/New_York:20170518T130000
DTSTAMP:20260502T115344
CREATED:20170104T165422Z
LAST-MODIFIED:20170104T165422Z
UID:408-1495108800-1495112400@www.ctnnortheastnode.org
SUMMARY:Science Series: Using SBIRT in pediatric populations - title TBD (Steven H. Chapman\, MD)
DESCRIPTION:Topic Description:  Stay tuned! \n  \nPresenter Bio:  Steven H. Chapman\, MD\, is a general pediatrician with 20 years of experience\, currently practicing at the Children’s Hospital at Dartmouth (CHaD) and teaching at Geisel School of Medicine at Dartmouth. He served four years in the National Health Service Corp and is currently the Director of the Boyle Community Pediatrics Program as well as Vice President of the New Hampshire Pediatric Society. He also serves on the Board of New Hampshire Kids Count/Children’s Alliance of New Hampshire\, and is the school physician for his local Dresden School District. He has particular interest in integrated behavioral health in primary care\, Screening\, Brief Intervention\, and Referral to Treatment (SBIRT) in primary care\, and support of parents in recovery who are raising young children.
URL:https://www.ctnnortheastnode.org/event/science-series-using-sbirt-pediatric-populations-title-tbd-steven-h-chapman-md/
LOCATION:Northeast Node Headquarters\, 46 Centerra Parkway\, Suite 315\, Lebanon\, NH\, 03766\, United States
CATEGORIES:Northeast Node
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20170316T120000
DTEND;TZID=America/New_York:20170316T130000
DTSTAMP:20260502T115344
CREATED:20161214T182213Z
LAST-MODIFIED:20170104T165252Z
UID:405-1489665600-1489669200@www.ctnnortheastnode.org
SUMMARY:Science Series: Parental Substance Misuse and Child Trauma (Mary Kay Jankowski\, PhD)
DESCRIPTION:Topic Description: Children exposed to parental substance misuse suffer from high rates of abuse\, neglect\, traumatic loss and posttraumatic sequelae.  Moreover\, an estimated 40-80% of families involved with child protection services due to child abuse or neglect involve substance abuse in the home.   With the high rates of substance use disorders including opioid use disorders\, and rising rates of death from drug overdose\, services to meet the needs of the children and youth whose parents are addicted to alcohol\, opioids and other drugs are sorely lacking.  This talk will provide an overview of the effects of parental substance misuse on children and youth\, with special focus on the association between parental substance misuse and child trauma.  Models for treating traumatized children that have high relevance and utility for children and youth coming from substance misusing families will be discussed. \n  \nPresenter Bio: Kay Jankowski\, PhD\, is an Assistant Professor in the Department of Psychiatry\, and Associate Director of the Dartmouth Trauma Interventions Research Center\, Dartmouth Hitchcock Medical Center. She received her Doctorate in Psychology from the University of Vermont and completed her internship and post-doctoral work at Geisel School of Medicine at Dartmouth.  Jankowski has published numerous articles and presented widely in the area of child and adolescent trauma\, including developing and testing new treatment interventions\, disseminating evidence-based practices into “real world settings”\, and transforming child serving systems to bring a more trauma-informed approach to care and services for children\, youth and their families.  Most recently she is the Principal Investigator for the New Hampshire Partners for Change Project\, a federally funded (ACF\, DHHS) demonstration project to improve the social and emotional well-being of children and youth in child welfare and juvenile justice systems.  She is also the Co-Principal Investigator for the federally funded New Hampshire Adoption Preparation and Preservation Project\, with a goal of promoting successful adoption by creating a trauma-informed\, evidence-based and adoption competent child welfare system. Jankowski also is a certified trainer for Trauma-Focused Cognitive Behavior Therapy (TF-CBT).  She provides training and consultation to clinicians across New England in the model\, as well as training in trauma-informed care to a range of organizations including mental health agencies\, substance abuse treatment centers\, organizations that serve homeless populations\, and schools\, and has expertise in leading learning collaborative models of practice change.  In addition\, she is an experienced clinical psychologist\, and maintains a practice\, treating traumatized children\, adolescents and adults at Dartmouth-Hitchcock.
URL:https://www.ctnnortheastnode.org/event/science-series-childhood-trauma-substance-use-title-tbd-mary-kay-jankowski-phd/
LOCATION:Northeast Node Headquarters\, 46 Centerra Parkway\, Suite 315\, Lebanon\, NH\, 03766\, United States
CATEGORIES:Northeast Node
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20170126T120000
DTEND;TZID=America/New_York:20170126T130000
DTSTAMP:20260502T115344
CREATED:20160404T220357Z
LAST-MODIFIED:20161214T181850Z
UID:283-1485432000-1485435600@www.ctnnortheastnode.org
SUMMARY:Science Series: Harnessing Digital Technologies in the Treatment of Substance Use Disorders (Lisa Marsch\, PhD)
DESCRIPTION:Topic\nA growing line of research has highlighted the promising role that interactive technologies (e.g.\, web\, mobile devices) may play in the assessment\, prevention\, treatment\, and recovery management of substance use disorders. In this presentation\, Dr. Marsch will provide an overview of the state of the science in the development\, evaluation\, and implementation of technology-based therapeutic interventions for substance use disorders. This research underscores the role that technology may play in improving treatment for substance use disorders in a manner that increases access to care\, is cost-effective\, ensures fidelity\, and enables the rapid diffusion and widespread adoption of science-based interventions. \n  \nAbout the Presenter\nDr. Lisa A. Marsch is the Director of the Dartmouth Center for Technology and Behavioral Health\, a designated “Center of Excellence” supported by the National Institute on Drug Abuse at the National Institutes of Health.
URL:https://www.ctnnortheastnode.org/event/science-series-harnessing-digital-technologies-treatment-substance-use-disorders-lisa-marsch-phd/
CATEGORIES:Northeast Node
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20161110T120000
DTEND;TZID=America/New_York:20161110T130000
DTSTAMP:20260502T115344
CREATED:20160912T151412Z
LAST-MODIFIED:20160912T200407Z
UID:376-1478779200-1478782800@www.ctnnortheastnode.org
SUMMARY:Science Series: The Safe Station Project (Christopher Hickey\, EMS Officer)
DESCRIPTION:Topic \nAn overview of the Safe Station program run by Manchester Fire Department and the partners involved.  The history\, how it came to be\, and identifying key components and concepts involved with the process.  You will be able to identify the key factors in your community to be able to start the discussion of whether or not the Safe Station Project is something your community can execute and what resources are needed to move the mission forward. \nAbout the Presenter \nChris is a certified career Firefighter I/II since 2004 and Nationally Registered Paramedic since 2000.  Currently\, he is a full time Firefighter Paramedic with the Lexington MA Fire Department and a fulltime Firefighter and EMS Officer for the Manchester NH Fire Department.  Prior to coming to the Manchester Fire Department\, Chris was a field paramedic\, Field Supervisor\, and Station Manager for Rockingham regional Ambulance and then American Medical Response.  Happily married to his wife of 17 years Melissa\, his family resides in Merrimack NH with their two boys Gavin (9) and Seamus (6) and their 5 year old boxer Bailey.  In his spare time\, he coaches Merrimack Youth Lacrosse and plays video games with his sons.
URL:https://www.ctnnortheastnode.org/event/science-series-manchesters-safe-station/
CATEGORIES:Northeast Node
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20160929T120000
DTEND;TZID=America/New_York:20160929T130000
DTSTAMP:20260502T115344
CREATED:20160404T215732Z
LAST-MODIFIED:20160727T151541Z
UID:282-1475150400-1475154000@www.ctnnortheastnode.org
SUMMARY:Science Series: Perinatal Substance Use Disorders: Rationale for Integrated Care (Daisy Goodman\, CNM\, DNP\, MPH)
DESCRIPTION:Topic\nPerinatal substance use disorders are a public health problem of increasing severity in northern New England\, straining the capacity of the maternity care system. Providing adequate and effective services for this vulnerable population requires an understanding of their complex needs. Because pregnancy is a time of high motivation for self-care\, women often seek treatment for substance use disorders for the first time after conception. Integrating addiction treatment with maternity care provides a unique opportunity to increase access\, address comorbid conditions\, and improve perinatal outcomes. \n  \nAbout the Presenter\nDaisy Goodman is a certified nurse midwife in clinical practice at Dartmouth Hitchcock Medical Center\, and an Instructor in Obstetrics and Gynecology at the Geisel School of Medicine at Dartmouth. She received a certificate in nurse-midwifery and women’s health at the Frontier Nursing University\, a Masters in Public Health from the Dartmouth Institute for Health Policy and Clinical Practice\, and a Doctorate in Nursing Practice at the Massachusetts General Hospital Institute of Health Professions. Her area of clinical and research interest is focused on improving access to care for pregnant women with opioid use disorders\, and on the intersection of trauma and substance use in women’s lives. Dr. Goodman currently practices at Dartmouth-Hitchcock Medical Center in the Department of Obstetrics and Gynecology\, and is part of the treatment team at the DHMC Perinatal Addiction Treatment Program. She is currently involved in the development of a toolkit to help standardize practice among maternity and addiction treatment providers caring for pregnant women with substance use disorders. Prior to coming to Dartmouth-Hitchcock in 2013\, she worked in the community hospital setting in Maine where she led implementation of a screening and brief intervention program in maternity care and participated in a workgroup sponsored by Maine CDC which developed state guidelines for the management of perinatal substance use.
URL:https://www.ctnnortheastnode.org/event/science-series-perinatal-substance-use-disorders-rationale-integrated-care-daisy-goodman-cnm-dnp-mph/
CATEGORIES:Northeast Node
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20160721T120000
DTEND;TZID=America/New_York:20160721T130000
DTSTAMP:20260502T115344
CREATED:20160404T213540Z
LAST-MODIFIED:20160405T155753Z
UID:279-1469102400-1469106000@www.ctnnortheastnode.org
SUMMARY:Science Series: Why Strategies to Integrate Behavioral Health in Primary Care are Unsuccessful and What Can Be Done About It? (Mark McGovern\, PhD)
DESCRIPTION:Topic\nWith the Affordable Care Act and Mental Health and Addiction Parity Act\, it is widely assumed that behavioral health care is in the midst of enormous transformation. Epidemiological studies and health services research document the high prevalence of behavioral health conditions in primary medical care settings\, and the significant costs associated with not addressing psychiatric and substance use disorders. A variety of behavioral health interventions\, both pharmacological and psychosocial\, have been developed and studied in primary care situations. Examples of evidence-based interventions include the Collaborative Care Model for Depression\, SBIRT for high risk alcohol use\, and medication-assisted treatment (MAT) for opioid use disorders. Although these treatments have consistently been found to pass efficacy and effectiveness trials\, they are not widely implemented—in fact few if any are sustained beyond the funded research time frame. Implementation science provides systematic insight into the barriers and facilitators of evidence-based practice adoption and reach in routine practice settings and health care systems. In this presentation\, the challenge of implementing and sustaining integrated behavioral health in primary care will be analyzed using a pragmatic research framework. Solutions are proposed that consider policy and financing; unified trans-diagnostic approaches to typical and complex behavioral health conditions (psychiatric and substance-related); optimization of care of individual providers and teams; and\, the role of technology-based platforms to enhance the quality of behavioral health care\, reduce practice variation\, and empower patients and families. \n  \nAbout the Presenter\nDr. Mark McGovern is a Professor of Psychiatry\, of Community & Family Medicine\, and of The Dartmouth Institute of Health Policy and Clinical Practice at the Geisel School of Medicine at Dartmouth in Lebanon New Hampshire USA. His clinical practice is based at the Hanover Psychiatry\, and his scientific program is focused on behavioral health services and implementation research.
URL:https://www.ctnnortheastnode.org/event/science-series-strategies-integrate-behavioral-health-primary-care-unsuccessful-can-done-mark-mcgovern-phd/
CATEGORIES:Northeast Node
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20160720T080000
DTEND;TZID=America/New_York:20160720T163000
DTSTAMP:20260502T115344
CREATED:20160404T210458Z
LAST-MODIFIED:20160513T173546Z
UID:274-1469001600-1469032200@www.ctnnortheastnode.org
SUMMARY:New England ATTC 2nd Annual Regional Adolescent Conference
DESCRIPTION:Co-sponsored by the Northeast Node of the CTN \nImproving Care of Adolescents with Substance Use Disorders: Effective Approaches to Assessing\, Treating\, and Engaging Teens \nThe New England ATTC is pleased to announce our 2nd annual regional adolescent conference! \nThis continuing education conference is designed for treatment providers and health care professionals who are looking to improve the care of adolescents affected by or at risk of substance use disorders. \nThis conference is relevant for professionals from a broad range of settings such as substance use treatment agencies\, primary care\, behavioral health care agencies\, juvenile justice\, schools\, child welfare\, recovery centers\, and other allied health settings.
URL:https://www.ctnnortheastnode.org/event/new-england-attc-2nd-annual-regional-adolescent-conference/
LOCATION:Dartmouth Hitchcock Medical Center\, One Medical Center Drive\, Lebanon\, NH\, 03756\, United States
CATEGORIES:Northeast Node
ORGANIZER;CN="ATTC Network":MAILTO:newenglandattc@brown.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20160519T120000
DTEND;TZID=America/New_York:20160519T130000
DTSTAMP:20260502T115344
CREATED:20160404T204807Z
LAST-MODIFIED:20160405T155957Z
UID:271-1463659200-1463662800@www.ctnnortheastnode.org
SUMMARY:Science Series: The Changing Landscape of Marijuana (Cannabis): What’s Real\, What’s Not (Alan Budney)
DESCRIPTION:Topic\nPerceptions about cannabis are changing. This webinar will discuss the potential impact of changes in cannabis laws and regulations\, limitations of the evidence for cannabis as a therapeutic substance\, and concerns related to adolescents’ use of cannabis and prevention messaging\, and how the changing landscape interacts with these issues. \n  \nAbout the Presenter\nDr. Alan Budney is a Professor at the Geisel School of Medicine at Dartmouth\, Co-Director of the Addiction and Health Research Laboratory\, and Director of the Treatment Development and Evaluation Core of the Center for Technology and Behavioral Health.
URL:https://www.ctnnortheastnode.org/event/science-series-changing-landscape-marijuana-cannabis-whats-real-whats-not/
CATEGORIES:Northeast Node
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20160421T173000
DTEND;TZID=America/New_York:20160421T183000
DTSTAMP:20260502T115344
CREATED:20160415T195517Z
LAST-MODIFIED:20160415T195517Z
UID:320-1461259800-1461263400@www.ctnnortheastnode.org
SUMMARY:Opioid Prescribing Update seminar
DESCRIPTION:D-H Substance Use and Mental Health Initiative Seminars on Substance Use\n Presenter(s): Gil Fanciullo MD\, MS\, DHMC Pain Services | Seddon Savage\, MD\, MS\, D-H Substance Use & Mental Health Initiative | Louis Kazal\, MD\, Heater Road Primary Care \nThis update is part of a series\, Seminars on Substance Use\, hosted by the Dartmouth-Hitchcock Substance Use and Mental Health Initiative. The series aims to provide information and discussion to support you in caring well for your patients around issues of drug and controlled substance use and misuse. Each session will include sharing of information and discussion of common issues\, challenges and potential solutions. \nProgram \nInformation (30 min) \n\nCurrent opioid use trends\nNew CDC opioid prescribing guidelines: content & implications\nFinal NH Board opioid prescribing rules\nPending NH legislation\n\nDiscussion! (30 min)
URL:https://www.ctnnortheastnode.org/event/opioid-prescribing-update-seminar/
LOCATION:Dartmouth Hitchcock Medical Center\, One Medical Center Drive\, Lebanon\, NH\, 03756\, United States
CATEGORIES:Northeast Node
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20160406T070000
DTEND;TZID=America/New_York:20160406T163000
DTSTAMP:20260502T115344
CREATED:20160401T152644Z
LAST-MODIFIED:20160404T203910Z
UID:266-1459926000-1459960200@www.ctnnortheastnode.org
SUMMARY:Maine Quality Counts Taking it To the Streets 2016: Building Clinical & Community Connections
DESCRIPTION:
URL:https://www.ctnnortheastnode.org/event/maine-quality-counts-taking-it-to-the-streets-2016/
CATEGORIES:Northeast Node
END:VEVENT
END:VCALENDAR